Results for tag: "Sialorrhea Drug"

Sialorrhea Drug is a type of Central Nervous System (CNS) drug used to treat excessive drooling. It is used to reduce the amount of saliva produced by the salivary glands, which can be caused by a variety of medical conditions, including neurological disorders, stroke, and head and neck cancer. Sialorrhea drugs are typically administered orally or through a nasogastric tube. Common side effects include dry mouth, nausea, and constipation. The Sialorrhea Drug market is a rapidly growing segment of the CNS drug market. It is driven by the increasing prevalence of neurological disorders, stroke, and head and neck cancer, as well as the growing awareness of the need for effective treatments for these conditions. Some companies in the Sialorrhea Drug market include Novartis, Pfizer, GlaxoSmithKline, Merck, and Sanofi. Show Less Read more